Nxstage Medical Inc (NXTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,207 | -5,144 | -21,402 | -16,838 | -11,560 |
| Depreciation Amortization | 11,580 | 5,720 | 23,087 | 17,415 | 11,459 |
| Accounts receivable | -1,851 | -1,779 | -1,773 | -3,414 | -1,753 |
| Accounts payable and accrued liabilities | -946 | -32 | -1,047 | 2,296 | 5,471 |
| Other Working Capital | -9,084 | -5,977 | -19,358 | -16,870 | -12,008 |
| Other Operating Activity | 11,394 | 5,804 | 18,977 | 13,671 | 4,720 |
| Operating Cash Flow | $886 | $-1,408 | $-1,516 | $-3,740 | $-3,671 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,953 | -1,564 | -5,156 | -3,330 | -1,999 |
| Investing Cash Flow | $-3,953 | $-1,564 | $-5,156 | $-3,330 | $-1,999 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -46 | -46 | -31 |
| Common Stock Issued | 3,656 | 2,115 | 7,965 | 6,471 | 3,898 |
| Common Stock Repurchased | -522 | N/A | -2,533 | -2,533 | -2,533 |
| Financing Cash Flow | $3,134 | $2,115 | $5,386 | $3,892 | $1,334 |
| Exchange Rate Effect | -117 | 213 | -144 | 86 | 423 |
| Beginning Cash Position | 102,909 | 102,909 | 104,339 | 104,339 | 104,339 |
| End Cash Position | 102,859 | 102,265 | 102,909 | 101,247 | 100,426 |
| Net Cash Flow | $-50 | $-644 | $-1,430 | $-3,092 | $-3,913 |
| Free Cash Flow | |||||
| Operating Cash Flow | 886 | -1,408 | -1,516 | -3,740 | -3,671 |
| Capital Expenditure | -3,953 | -1,564 | -5,156 | -3,330 | -1,999 |
| Free Cash Flow | -3,067 | -2,972 | -6,672 | -7,070 | -5,670 |